Perth-based neurological drug developer Argenica Therapeutics has been knocked back by the US Food and Drug Administration, dashing hopes its US clinical trials would soon start.
The state government has awarded a tender to more than a dozen companies which will receive about $375 million worth of technology infrastructure work.
The Legal Practice Board of WA has become the latest target of a cyber attack, after hackers accessed bank details and other information of legal professionals.
A local cybersecurity and privacy partner has warned businesses not to ‘recklessly delay’ investing in protecting their data following several cyberattacks in Perth.
Perth software companies INX Software and K2fly have completed their merger, rebranding as Quartex while also committing to remaining headquartered in Perth.
Murdoch-based Orthocell’s push to expand the reach of its nerve repair product Remplir has continued, following news it has received regulatory approval in Hong Kong.
Orthocell boss Paul Anderson said the Murdoch-based biotech medical company is “well ahead” of its original targets in relation to US sales of its nerve repair product, Remplir.
FBR shareholders have overwhelmingly endorsed all three resolutions at the company’s extraordinary general meeting on Tuesday, following a late push to have it deferred.
DUG Technology managing director Matthew Lamont is excited by the company’s future, as it continues to move forward with its elastic MP-FWI imaging technology.
Shares in Murdoch-based Orthocell rose by 15 per cent early on Wednesday, following news the biotech medical company had received regulatory approval to sell its nerve repair product in Canada.
Fresh from receiving clearance from the Food and Drug Administration to distribute its nerve repair product Remplir in the US earlier this month, Murdoch-based Orthocell has appointed an initial four distributors.
Perth-based Track'em, which counts some of WA’s largest resources companies as clients, has struck a partnership with UK-based industrial software giant AVEVA.
Pentanet may have kept up the earnings momentum this quarter, but investors appear unimpressed as the telco’s shares took another tumble on Wednesday morning.